Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Lipoprotein(a) cascade screening in coronary artery disease.

Atherosclerosis - 1 Jun 2026

Littmann Karin, Eriksson Hogling Daniel, Suhel Mustafa, Juhlin Kamilla, Kara Pinar, Bottai Matteo, Svedberg Niclas, Nordenskjöld Anna M, Ekström Mattias, Mellbin Linda, Grimfjärd Per, Erlinge David, Hagström Emil, Brinck Jonas

Abstract excerpt

BACKGROUND AND AIM: Elevated lipoprotein(a) [Lp(a)] contributes to coronary artery disease (CAD). This study aimed to determine the effectiveness of cascade screening for elevated Lp(a) in patients with CAD. METHODS: Lp(a)-based cascade screening in first-degree relatives (FDR) and second-degree relatives (SDR) of index patients with CAD was performed. Index patients were recruited into pre-defined Lp(a) strata:...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Biomarkers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Coronary Artery Disease

Share to Lipoprotein(a)

Share to Mass Screening

Share to Predictive Value of Tests

Share to Risk Factors

Share to Up-Regulation

Source

Identifiers

PMID: 42066440
DOI: 10.1016/j.atherosclerosis.2026.120759

Genes

CAD

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Lipoprotein(a) cascade screening in coronary artery disease.PMID 42066440Read ↗

Familial Hypercholesterolemia and Elevated Lipoprotein(a): Cascade Testing and Other Implications for Contextual Models of CareSemantic proximity Read ↗

Cascade testing of children and adolescents for elevated Lp(a) in pedigrees with familial hypercholesterolaemiaSemantic proximity Read ↗

Impact of elevated lipoprotein(a) on coronary artery disease phenotype and severity.Semantic proximity Read ↗

Lipoprotein(a): An independent, genetic, and causal factor for cardiovascular disease and acute myocardial infarctionSemantic proximity Read ↗

Elevated lipoprotein(a) and genetic polymorphisms in the LPA gene may predict cardiovascular events.Semantic proximity Read ↗

Familial Hypercholesterolemia, Familial Combined Hyperlipidemia, and Elevated Lipoprotein(a) in Patients With Premature Coronary Artery Disease.Semantic proximity Read ↗

Significance of lipoprotein(a) levels in familial hypercholesterolemia and coronary artery disease.Semantic proximity Read ↗

Beyond Cholesterol: A Comprehensive Review and Disease Architecture Reassessment of Lipid and Lipoprotein Biomarkers in ASCVDSemantic proximity Read ↗

Lipoprotein(a) and Traditional Risk Factors as Predictors of Premature Coronary Artery Disease: A Single-Center Retrospective StudySemantic proximity Read ↗

Associations of Genetically Predicted Lp(a) (Lipoprotein [a]) Levels With Cardiovascular Traits in Individuals of European and African Ancestry.Semantic proximity Read ↗

Daring to dream: Targeting lipoprotein(a) as a causal and risk-enhancing factorSemantic proximity Read ↗

Lipoprotein(a): new insights from modern genomicsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.